These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23403423)

  • 1. A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.
    Tejman-Yarden N; Miyamoto Y; Leitsch D; Santini J; Debnath A; Gut J; McKerrow JH; Reed SL; Eckmann L
    Antimicrob Agents Chemother; 2013 May; 57(5):2029-35. PubMed ID: 23403423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
    Leitsch D
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for inactivation of Giardia lamblia carbamate kinase by disulfiram.
    Galkin A; Kulakova L; Lim K; Chen CZ; Zheng W; Turko IV; Herzberg O
    J Biol Chem; 2014 Apr; 289(15):10502-10509. PubMed ID: 24558036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel antigiardiasis drug candidates.
    Kulakova L; Galkin A; Chen CZ; Southall N; Marugan JJ; Zheng W; Herzberg O
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7303-11. PubMed ID: 25267663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseases.
    Debnath A; Ndao M; Reed SL
    Gut Microbes; 2013; 4(1):66-71. PubMed ID: 23137963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viability Screen of LOPAC
    Yason JA; Koh KARP; Tan KSW
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866860
    [No Abstract]   [Full Text] [Related]  

  • 7. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
    Lemée V; Zaharia I; Nevez G; Rabodonirina M; Brasseur P; Ballet JJ; Favennec L
    J Antimicrob Chemother; 2000 Nov; 46(5):819-21. PubMed ID: 11062206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasis.
    Escrig JI; Miyamoto Y; Aznar AD; Eckmann L; Debnath A
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0073123. PubMed ID: 38063401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent.
    Capparelli EV; Bricker-Ford R; Rogers MJ; McKerrow JH; Reed SL
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological aspects of nitro drug resistance in Giardia lamblia.
    Müller J; Hemphill A; Müller N
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):271-277. PubMed ID: 29738984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia.
    Kim WJ; Korthals KA; Li S; Le C; Kalisiak J; Sharpless KB; Fokin VV; Miyamoto Y; Eckmann L
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396548
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target.
    Leitsch D; Müller J; Müller N
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):148-153. PubMed ID: 27485086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
    Reyes-Vivas H; de la Mora-de la Mora I; Castillo-Villanueva A; Yépez-Mulia L; Hernández-Alcántara G; Figueroa-Salazar R; García-Torres I; Gómez-Manzo S; Méndez ST; Vanoye-Carlo A; Marcial-Quino J; Torres-Arroyo A; Oria-Hernández J; Gutiérrez-Castrellón P; Enríquez-Flores S; López-Velázquez G
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7072-82. PubMed ID: 25223993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.
    Tejman-Yarden N; Millman M; Lauwaet T; Davids BJ; Gillin FD; Dunn L; Upcroft JA; Miyamoto Y; Eckmann L
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4643-51. PubMed ID: 21825286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccharomyces boulardii as therapeutic alternative in experimental giardiasis.
    Ribeiro MRS; Oliveira DR; Caliari MV; Cara Machado DC; Andrade MER; Cardoso VN; Dos Santos Martins F; Nicoli JR; Gomes MA
    J Appl Microbiol; 2021 Jul; 131(1):460-469. PubMed ID: 33289232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metronidazole analogues on Giardia lamblia: experimental infection and cell organization.
    Busatti HG; Alves RJ; Santana-Anjos KG; Gil FF; Cury MC; Vannier-Santos MA; Gomes MA
    Diagn Microbiol Infect Dis; 2013 Feb; 75(2):160-4. PubMed ID: 23331963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs.
    Nillius D; Müller J; Müller N
    J Antimicrob Chemother; 2011 May; 66(5):1029-35. PubMed ID: 21393225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giardiasis: a pharmacotherapy review.
    Escobedo AA; Cimerman S
    Expert Opin Pharmacother; 2007 Aug; 8(12):1885-902. PubMed ID: 17696791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising effects of 1,8 Cineole to control Giardia lamblia infection: Targeting the inflammation, oxidative stress, and infectivity.
    Masoori L; Khalaf AK; Ezzatkhah F; Balaña-Fouce R; Mahmoudvand H
    Acta Trop; 2024 Jul; 255():107201. PubMed ID: 38604329
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Morales-Luna L; Hernández-Ochoa B; Martínez-Rosas V; Navarrete-Vázquez G; Ortega-Cuellar D; Rufino-González Y; González-Valdez A; Arreguin-Espinosa R; Franco-Vásquez AM; Pérez de la Cruz V; Enríquez-Flores S; Martínez-Conde C; Canseco-Ávila LM; Gómez-Chávez F; Gómez-Manzo S
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.